Novo Nordisk says it plans to apply for regulatory approval of its sickle cell disease, etavopivat, in the second half of ...

Netflix faces near-term pressure from competition and debt, but subscriber growth, strong engagement and diversified content strategy support long-term expansion.

Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), PepsiCo, Inc. (PEP) and Novo Nordisk A/S (NVO), as well as two micro-cap stocks, Hawthorn ...

During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral ...

Alongside the $399 monthly dose, patients can choose to get a two-month supply for $798 or a three-month supply for $1,197.

MoU to support structured, hospital-based metabolic and weight management care, with the first phase set to begin at 10 KPJ ...

See which leaders are on the move across the pharma, biotech and medical marketing industries.

Eli Lilly (LLY 1.85%) has accomplished something big over the past year. It's become the leading weight loss drug company in ...

The Eagles have their first new player in the Luke Murray era.

LEBANON, N.H., April 15, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently ...

Even as demand for blockbuster GLP-1 weight-loss drugs explodes, Jefferson Health’s own employees are mostly watching from ...

Hemab Therapeutics is advancing antibody-based therapies for rare blood coagulation disorders, targeting subcutaneous ...